Post Nordic innovation in the spotlight at NLSDays: Vesper Bio wins pitch competition, Veltio Pharma tops innovation poster exhibition
Post “As an investor we’re often thinking about how to guide the company to a particular exit scenario”
Post Karin Conde-Knape, Senior Vice President of Global Drug Discovery at Novo Nordisk, about NLSDays Grand Opening
Post Mike Ryan, Executive Vice President, Europe, Eversana about NLSDays’ Vaccine Crosslinks: From Cancer to COVID super session
